deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke

REYKJAVIK, Iceland, July 13 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (Nasdaq: DCGN ) and colleagues from Europe and the United States today report the discovery of a common single-letter variant in the sequence of the human genome (SNP) conferring increased risk of atrial fibr...

King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use

ACUROX(R) and EMBEDA (TM) Data Highlighted at the College on Problems of Drug Dependence Annual Meeting RENO, Nev., June 25 /PRNewswire/ -- King Pharmaceuticals, Inc. (NYSE: KG ) today announced that the Company is presenting safety and efficacy data for ACUROX(R) and EMBEDA(TM) (ALO-01...

Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation

St. Jude study shows personalized chemotherapy can improve cure rate and avoid the use of radiation in acute lymphoblastic leukemia treatment MEMPHIS, Tenn., June 24 /PRNewswire-USNewswire/ -- Childhood acute lymphoblastic leukemia (ALL) can be successfully treated using a carefully person...

Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis

- Eight Studies Presented at Leading Urology Meeting Show that Simple Urine Test for PCA3 Gene May Improve Accuracy of Prostate Cancer Detection, Reduce Unnecessary Biopsies - - Gen-Probe to Begin Pivotal Clinical Study in Effort to Gain U.S. Regulatory Approval - SAN DIEGO, ...

A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer

REYKJAVIK, Iceland, Jan. 18 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (Nasdaq: DCGN ) and colleagues from the US and ten European countries today announced a long-awaited first in cancer research: the discovery of common single-letter variations in the human genome (SNPs) linke...

Atrial Fibrillation Found to be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke

TOKYO, November 7 /PRNewswire/ -- - Large, International REACH Registry Also Shows Many Patients With Atrial Fibrillation are Undertreated With Antiplatelet and Anticoagulant Therapies A significant portion of patients with atherothrombosis also have atrial fibrillation (AF), greatly incre...

deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer

Detection may be used to complement and target screening for the disease; findings will be integrated into the deCODEme(TM) personal genome scan. REYKJAVIK, Iceland, Sept. 14 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (Nasdaq: DCGN ) and colleagues at Radboud University Medical ...

TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration

- Multicenter study finds unique combination of micronutrients superior to current 'AREDS' standard of care; Results supported by new omega-3 study - HOUSTON, Sept. 10 /PRNewswire/ -- A landmark study at five university-based research centers found that TOZAL(R), a patented combination of anti...

New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery

Novel Pain Medicine Studied in Patients Following Bunionectomy TAMPA, Fla., May 9 /PRNewswire-USNewswire/ -- Many foot-surgery patients experience intense pain for several days following removal of a bunion, one of the most common foot surgeries. The investigational pain medication tapen...

deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases

REYKJAVIK, Iceland, March 16 /PRNewswire-FirstCall/ -- In a paper published online today in the journal Nature, a team of deCODE scientists detail a major mechanism through which genetic factors contribute to major public health problems. In its work on the inherited components of dozens of co...

Gene Hunters Fine-Tune Marker for Common Obesity Gene

- In Children's DNA, a Hint of a Mutation's Ancestral African Origin - PHILADELPHIA, March 12 /PRNewswire-USNewswire/ -- Genomics researchers, seeking to replicate another group's discovery of an important gene associated with obesity, have further refined the signal to a particular varian...

New Data Published in The Lancet Show GSK's ROTARIX(R) Offers Protection Against the Most Common Circulating Rotavirus Types

Protection Sustained During the First Two Years of Life PHILADELPHIA, Nov. 23 /PRNewswire-FirstCall/ -- New data from a large European clinical trial published today in The Lancet show ROTARIX(R), GlaxoSmithKline's (NYSE: GSK ) oral rotavirus candidate vaccine to prevent rotavirus gas...

Obesity Common in Children with Heart Disease

PHILADELPHIA, Nov. 1 /PRNewswire-USNewswire/ -- Obesity is common in children with heart disease, a population already at increased risk of a shortened life expectancy. More than 25 percent of children with congenital and acquired heart disease are overweight or obese, say researchers from T...

Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee

ROCKVILLE, Md., Oct. 4 /PRNewswire-USNewswire/ -- A new scientific review released today by HHS' Agency for Healthcare Research and Quality concludes that evidence of benefit is lacking for many common ways of treating osteoarthritis of the knee, including popular dietary supplement ingredient...

Genetics Determine Optimal Drug Dose of Common Anticoagulant

WASHINGTON, Aug. 21 /PRNewswire-USNewswire/ -- Genetic testing can be used to help personalize the therapeutic dosage of warfarin, a commonly-used anticoagulant, according to research published in the September 1, 2007, issue of Blood, the journal of the American Society of Hematology. This re...

Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery

OAK BROOK, Ill., Aug. 16 /PRNewswire-USNewswire/ -- New research from the Washington University School of Medicine in St. Louis, Mo. indicates that endoscopic balloon dilation is a safe and effective method in treating gastrojejunal anastomotic strictures (a narrowing of the opening made betwe...

Study Finds Repeated Episodes of Stent Thrombosis Common

Treating stent thrombosis with another stent hikes the risk of repeat blood clotting CHICAGO, March 29 /PRNewswire/ -- When a clot develops inside a coronary stent, it can block blood flow to the heart, potentially causing a heart attack or even death. A single inc...

One-Third of Patients Discontinue Common Breast Cancer Therapy

PRINCETON, N.J.--(BUSINESS WIRE)--Mar 15, 2007 - An alarming study that appeared in the March 1, 2007 issue of CANCER (a peer-reviewed journal of the American Cancer Society), reports that one-third of women taking the standard five-year regimen of the hormonal breast cancer treatment tamoxifen cit...

Trichomoniasis: Most Common Curable STD in U.S. Affects 7.4 Million Annually

April is STD Awareness Month: Time to Pay Attention to this Overlooked Disease SAN ANTONIO, Texas, April 02, 2007 /PRNewswire/ -- During National Sexually Transmitted Disease (STD) Awareness Month this April, Mission Pharmacal is urging increased awareness of, and testing for, trichomoniasis (also...

Researchers Discover a Common Variation in a Gene Segment that Increases the Risk for Prostate Cancer

BETHESDA, Md., April 1, 2007--Researchers report that a variation in a portion of DNA strongly predicts prostate cancer risk and that this common variation may be responsible for up to 20 percent of prostate cancer cases in white men in the United States. The research was conducted by investigator...

Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant

Study shows paroxetine produced no significant drug interaction with paliperidone ER SAN DIEGO, May 22, 2007 /PRNewswire/ -- After administration of paliperidone extended-release (ER) tablets, blood levels of the drug were not affected when given with a common antidepressant, according to new data...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

.... About Colorectal Cancer Colorectal cancer is the fourth most common cancer in men and the third most common cancer in women worldwide. In 2007, approximately 1.2 million cases of colo...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...tributable to Isis Pharmaceuticals, Inc. common stockholders $(2,896) $(3,737) $168,9...tributable to Isis Pharmaceuticals, Inc. common stockholders $(6,492) $5,729 $(3...utable to Isis Pharmaceuticals, Inc. common stockholders $(0.07) ...

Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis

...novel PTHrP (parathyroid hormone-related protein) analog -- significantly increased bone mineral density (BMD) at the lumbar spine and femoral neck (a common fracture site located in the hip joint) after six months of therapy. The gains in lumbar spine and femoral neck BMD were further increased in a subset...

Labopharm files New Drug Submission with Health Canada for novel antidepressant

... study are found in the May 2009 issue of Psychiatry (Edgemont) (Volume 6, Number 5) ( www.psychiatrymmc.com ). Major depressive disorder (MDD) is a common mental illness often characterized by a combination of symptoms that interfere with a person's ability to work, sleep, study, eat, and enjoy once-plea...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

...y: Preferred stock $- $- common stock 9 9 Capital in exce... (616) (1,151) Proceeds from issuances of common stock 90 383 ...

ARUP Laboratories Applauds FDA's Decision on the Value of KRAS-Mutation Testing in Colorectal Cancer

...nti-EGFR Therapy ," elaborates on this testing and can be found at www.aruplab.com. "In the United States, colorectal cancer is the third most common form of cancer and individuals have a 6 percent lifetime risk of developing this disease," said Executive Vice President of Corporate Communications R...

Project Zero Delay Accelerates Drug's Path to Clinical Trial

...site visits and preparation, training and a series of mandatory institutional reviews at M. D. Anderson. "M.D. Anderson and AstraZeneca share a common goal of using leading edge science to deliver medicines that will benefit patients now and in the future, while speeding up the process and making it ...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

...or physicians, caregivers and patients. In clinical trials, the most common adverse events (incidence greater than or equal to 5% and occurring at leas...hurt yourself. In a study of people taking INVEGA((R)) SUSTENNA(TM), common side effects in the treatment of schizophrenia were reactions at the inject...

Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA

...g degrees of severity, it has been sub-divided in three subtypes according to the presence or absence of neurological involvement. It is also the most common genetic disease affecting Ashkenazi Jewish people (Eastern, Central and Northern European ancestry), with a carrier frequency of 1 in 10 (Dr. John Bar...

British Woman Celebrates a Year of Living Cancer-Free

... years ago. AML is a cancer of the myeloid line of blood cells and the most common acute leukemia among adults. "I was shocked that I had leukemia," M...umulate in the bone marrow and impede the production of normal blood cells. common courses of treatment include chemotherapy, radiation therapy and bone marro...

Popular Breast Cancer Drug Used with Certain Antidepressants Puts New Jersey Women at Risk

...es when taken with tamoxifen. Antidepressants are often prescribed when women receiving tamoxifen are depressed, or to treat hot flashes -- a common side effect of the breast cancer drug. Paxil, Prozac and Zoloft are among a group of antidepressant drugs known as CYP2D6 inhibitors. These drugs pre...

Is Your Hair Taking a Break?

...oss." Female-Pattern Hair Loss The most common form of hair loss in women is female-pattern hair ...er hair loss. Telogen Effluvium Another common form of hair loss in both men and women, telogen e...s) and/or other areas of the body. While not as common as other forms of hair loss, this condition can be...

Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin

...nce did and that it is drier than normal. In order to treat the most common symptoms associated with menopause -- including hot flashes, mood swings an...e many effective therapies that dermatologists regularly use to address the common signs of aging -- including retinoids, alpha-hydroxy acids and other topica...

Diabetes Gene Raises Odds of Lower Birth Weight

...produces too little insulin or when the body cannot efficiently use the insulin that is produced. Formerly called adult-onset diabetes and still most common in adults, type 2 diabetes has been increasing sharply among children. Grant and study co-leader Hakon Hakonarson, Ph.D., director of the Cent...

FDA Issues Complete Response Letter for INTUNIV(TM) (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents

...erally mild to moderate in severity, with the most common side effects being sedative in nature.(1,2) Sedati...atment-emergent adverse events were among the most common and were usually transient and mild to moderate in...) About ADHD ADHD is one of the most common psychiatric disorders in children and adolescents....

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

... the study. The data also showed that dirucotide was generally well tolerated. There were no unexpected safety or tolerability issues. The most common side effect reported was injection site reaction. More details of the MAESTRO-01 study results are expected to be presented at a medical conference la...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

... Safety Results Similar to TASKi2, the most common clinically meaningful drug-related adverse events ...linical trial with minimal safety issues. The most common adverse events in the trial overall were related t... blood pressure medications were standard doses of common blood pressure medications such as ACE inhibitors ...

First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center

...ess at the 51st annual meeting of the American Association of Physicists in Medicine on July 26-30 in Anaheim, Calif. Skin cancer is the most common cancer in the United States with more than 1 million cases diagnosed annually and results in more than 10,000 deaths each year, according to the Natio...

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

...hma in the United States(3), it is one of the most common and costly chronic diseases.(2) Annually, this dis...tact your health care provider. The most common side effects with ASMANEX in patients 4-11 years o...ary tract infection, and bruise. The most common side effects with ASMANEX in patients greater than...